SKI Market

Indian Indices

Sensex

79,686.66 -329.24
( -0.41%)

Global Indices

Nasdaq

47,963.68 -796.74
(-1.63%)

Dow Jones

6,850.98 -39.52
(-0.57%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,430.91 -136.74
(-1.29%)

Forex

USD-INR

92.13 0.17
(0.19%)

EUR-INR

107.06 0.12
(0.11%)

GBP-INR

123.03 0.33
(0.27%)

JPY-INR

0.59 0.00
(0.39%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.12

2785.85

EPS(TTM)

Face Value()

Div & Yield %

5.04

0.04

Back

kay power & paper ltd

Endurance Technologies consolidated net profit rises 11.97% in the September 2025 quarter

Nov 13,2025

Net profit of Endurance Technologies rose 11.97% to Rs 227.27 crore in the quarter ended September 2025 as against Rs 202.98 crore during the previous quarter ended September 2024. Sales rose 23.01% to Rs 3582.82 crore in the quarter ended September 2025 as against Rs 2912.66 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3582.82	2912.66	23
OPM %	13.31	13.12	-
PBDT	484.15	396.92	22
PBT	304.13	265.77	14
NP	227.27	202.98	12

79,686.66 -329.24 ( -0.41%)

47,963.68 -796.74 (-1.63%)

6,850.98 -39.52 (-0.57%)

55,141.42 895.88 (1.65%)

10,430.91 -136.74 (-1.29%)

92.13 0.17 (0.19%)

107.06 0.12 (0.11%)

123.03 0.33 (0.27%)

0.59 0.00 (0.39%)